Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment.

Background: Pyogenic sterile arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome (OMIM 604416) is a rare autosomal dominant inherited autoinflammatory syndrome characterized by pyogenic sterile arthritis and less frequently accompanied by pyoderma gangrenosum and acne. It is associated with do...

Descripción completa

Detalles Bibliográficos
Publicado en:JAMA Dermatology Vol. 149; no. 2; pp. 209 - 216
Autores principales: Geusau, Alexandra, Mothes-Luksch, Nadine, Nahavandi, Hesam, Pickl, Winfried F, Wise, Carol A, Pourpak, Zahra, Ponweiser, Elisabeth, Eckhart, Leopold, Sunder-Plassmann, Raute
Formato: case study Journal Article
Publicado: American Medical Association Feb2013
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104238260&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104238260
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        21686068
        FTFQ
      jtl: JAMA Dermatology
      issn: 21686068
      maglogo: N
    pubinfo:
      dt: Feb2013
      vid: 149
      iid: 2
      pid: 30
      pub: American Medical Association
      place: Chicago, Illinois
    artinfo:
      ui:
        104238260
        NLM23426477
        2012017412
        10.1001/2013.jamadermatol.717
        NLM23426477
        104238260
      ppf: 209
      ppct: 7
      formats:
      tig:
        atl: Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment.
      aug:
        au:
          Geusau, Alexandra
          Mothes-Luksch, Nadine
          Nahavandi, Hesam
          Pickl, Winfried F
          Wise, Carol A
          Pourpak, Zahra
          Ponweiser, Elisabeth
          Eckhart, Leopold
          Sunder-Plassmann, Raute
        affil: Division of Immunology, Allergy, and Infectious Diseases, Department of Dermatology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria. alexandra.geusau@meduniwien.ac.at
      sug:
        subj:
          Acne Vulgaris Drug Therapy
          Carrier Proteins
          Antibodies, Monoclonal Therapeutic Use
          Arthritis, Infectious Drug Therapy
          Cytoskeletal Proteins
          Interleukin 1 Antagonists and Inhibitors
          Pyoderma Gangrenosum Drug Therapy
          Acne Vulgaris
          Acne Vulgaris Pathology
          Amino Acids
          Arthritis, Infectious
          Arthritis, Infectious Pathology
          Male
          Mutation
          Pyoderma Gangrenosum
          Pyoderma Gangrenosum Pathology
          Disease Remission
          Sequence Analysis
          Syndrome
          Treatment Outcomes
          Young Adult
          Male
      ab: Background: Pyogenic sterile arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome (OMIM 604416) is a rare autosomal dominant inherited autoinflammatory syndrome characterized by pyogenic sterile arthritis and less frequently accompanied by pyoderma gangrenosum and acne. It is associated with dominant missense mutations in the proline-serine-threonine phosphatase-interacting protein 1 gene (PSTPIP1) located on chromosome 15. The patient was diagnosed as having features of a PAPA-like syndrome in which cutaneous manifestations, such as pyoderma gangrenosum and acne fulminans, predominated.Observations: Sequencing of the PSTPIP1 gene was performed in the patient and his extended family. The patient's DNA analysis revealed a homozygous nucleotide exchange c.773G>C in the PSTPIP1 gene, leading to the substitution of glycine 258 by alanine (p.Gly258Ala), a previously reported heterozygous polymorphism. Heterozygous changes were identified in both of the patient's parents and in 7 other family members, all of whom were asymptomatic. The patient was treated with canakinumab, a human anti-interleukin 1β monoclonal antibody, which led to rapid remission of the symptoms.Conclusions: To our knowledge, this is the first reported case of the resolution of dermatological symptoms associated with a PAPA-like syndrome using canakinumab treatment. Further study of the p.Gly258Ala variant is warranted to determine whether this mutation has a role in causing an apparently recessive cutaneous syndrome resembling PAPA syndrome.
      pubtype: Academic Journal
      doctype:
        case study
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N